TD Cowen Maintains Argenx SE(ARGX.US) With Buy Rating
TD Cowen Remains a Buy on Argenx Se (ARGX)
Wedbush Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $560
UBS Keeps Their Hold Rating on Argenx Se (ARGX)
Argenx Analyst Ratings
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $635
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Raymond James Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $605
Argenx Analyst Ratings
Raymond James Reinstates Strong Buy on Argenx, Announces $605 Price Target
Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $547
Piper Sandler Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $553
Morgan Stanley Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $580
Buy Rating Justified by Argenx Se's Promising Vyvgart Launch and Strong Sales Outlook
Argenx Analyst Ratings
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $598
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $547 to $610
Piper Sandler Reaffirms Their Buy Rating on Argenx Se (ARGX)
Buy Rating Affirmed for Argenx Se Amid Vyvgart's Favorable Efficacy and Safety Profile Over Uplizna